The Top Five Cyber Threats Impacting Every Industry (And How To Avoid Them)
June 03, 2024 07:02 ET
|
INE
Cary, NC, June 03, 2024 (GLOBE NEWSWIRE) -- New data from the FBI shows that 2023 was a record year for cybersecurity claims for Americans, with potential losses exceeding $12.5 billion. INE...
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
June 03, 2024 07:01 ET
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate...
Fortrea to Present at the Jefferies Global Healthcare Conference
June 03, 2024 07:00 ET
|
Fortrea Holdings Inc
DURHAM, N.C., June 03, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and...
Alma íbúðafélag hf.: Útboð á víxlum 6. júní 2024
June 03, 2024 07:00 ET
|
Alma íbúðafélag hf.
Alma íbúðafélag hf.: Útboð á víxlum 6. júní 2024 ALMA íbúðafélag hf. heldur lokað útboð á þriggja mánaða óverðtryggðum víxlum (AL 24 0915) og sex mánaða óverðtryggðum víxlum (AL 24 1215)...
At ASCO 2024, Treos Bio Reports Key Survival Results for Chemo-Free Regimen of PolyPEPI1018 Peptide Immunotherapy and Roche’s PD-L1 Inhibitor in Late-Stage Colorectal Cancer
June 03, 2024 07:00 ET
|
Treos Bio Corp.
Treos Bio reports promising survival results for chemo-free PolyPEPI1018 cancer vaccine combined with Roche's PD-L1 inhibitor in MSS mCRC at 2024 ASCO
Stallion Uranium Closes Sale of Non-Core Uranium Projects in Eastern Athabasca Basin
June 03, 2024 07:00 ET
|
Stallion Uranium Corp.
Stallion Uranium Closes Sale of Non-Core Uranium Projects in Eastern Athabasca Basin
Canoo Announces Participation in June Investor Conferences
June 03, 2024 07:00 ET
|
Canoo, Inc.
Canoo will participate in the upcoming Stifel Cross Sector Insight and Sidoti Small Cap investor conferences.
Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
June 03, 2024 07:00 ET
|
Century Therapeutics, Inc.
In ongoing dose escalation, CNTY-101 has demonstrated a manageable safety profile with no observed DLTs or GvHD and with majority of patients treated in outpatient setting Encouraging preliminary...
Introba Appoints Gary Hamilton as Senior Vice President – Growth Leader, Americas
June 03, 2024 07:00 ET
|
Introba
St. Louis, MO, June 03, 2024 (GLOBE NEWSWIRE) -- Introba, a global building engineering and consulting firm, has strengthened its leadership team by appointing Gary Hamilton as Senior Vice President...
HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation
June 03, 2024 07:00 ET
|
HighLife
HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation Paris, June 3rd 2024 - HighLife SAS, a medtech company focused on the development of a novel...
- June 03, 2024 07:00 ET University of Rochester’s Eastman School of Music Recognized in the QS World University Rankings
- June 03, 2024 07:00 ET Introba Appoints Gary Hamilton as Senior Vice President – Growth Leader, Americas